세일즈 담당자와 상담을 받으세요.
상담하기
Lunit
KO
EN
제품 문의하기
루닛은 증거에 기반한 AI를 개발합니다.
루닛의 연구 결과
Latest
Latest
AI
Breast
Chest
Oncology
Reference library
Clear filters
Journal of Clinical Oncology
The LANCET Digital Health
JAMA Oncology
Radiology
Clinical Cancer Research
European Journal of Cancer
CVPR
ICCV
ECCV
MICCAI
NeurIPS
ICLR
ELSEVIER
Others
Publications
Oncology
Use of artificial intelligence-powered spatial analysis of tumor microenvironment to predict the prognosis in resected gallbladder cancer.
AUTHOR
Young Hoon Choi et al.
PUBLICATION
ASCO 2025
Read more
Oncology
Artificial Intelligence-based tumor microenvironment and PD-L1 analysis using digital pathology to predict pembrolizumab response in metastatic triple-negative breast cancer.
AUTHOR
Jee Hung Kim et al.
PUBLICATION
ASCO 2025
Read more
Oncology
A large validation study of AI-powered PD-L1 analyzer compared to pathologists’ assessment of PD-L1 expression in lung cancer.
AUTHOR
Yoshitaka Zenke et al.
PUBLICATION
ASCO 2025
Read more
Oncology
Artificial intelligence-powered spatial analysis of tumor microenvironment in non-small cell lung cancer patients who acquired resistance after EGFR tyrosine kinase inhibitors.
AUTHOR
Yeong Hak Bang et al.
PUBLICATION
ASCO 2025
Read more
Oncology
Artificial intelligence-powered spatial analysis of tumor infiltrating lymphocytes and tertiary lymphoid structures in non-small cell lung cancer patients treated with immune-checkpoint inhibitors±chemotherapy.
AUTHOR
Yeong Hak Bang et al.
PUBLICATION
ASCO 2025
Read more
Oncology
Deep learning–powered H&E whole-slide image analysis of endothelial cells to characterize tumor vascular environment and correlate treatment outcome to immunotherapy.
AUTHOR
Seungeun Lee et al.
PUBLICATION
ASCO 2025
Read more
Oncology
Use of artificial intelligence (AI)–powered spatial analysis to predict pathologic complete response (pCR) in HR+ HER2- breast cancer (BC) patients treated with neoadjuvant chemotherapy (NAC).
AUTHOR
Dae-Won Lee et al.
PUBLICATION
ASCO 2025
Read more
Oncology
Deep learning to predict treatment response of immune checkpoint inhibitors from pretreatment chest X-rays in non–small-cell lung cancer.
AUTHOR
Woochan Hwang et al.
PUBLICATION
ASCO 2025
Read more
Oncology
Membrane-specific HER2 expression by artificial intelligence-based quantitative scoring for prediction of efficacy of trastuzumab deruxtecan in biliary tract cancer (HERB trial): Exploratory analysis of a multicenter, single arm, phase II trial.
AUTHOR
Mitsuho Imai et al.
PUBLICATION
ASCO 2025
Read more
Oncology
Artificial intelligence (AI)-powered evaluation of protein drug-targetability through subcellular-level expression profiling from immunohistochemistry (IHC) images.
AUTHOR
Sukjun Kim et al.
PUBLICATION
ASCO 2025
Read more
1
2
3
4
5